Ligand Pharmaceuticals Incorporated Income Statement and Balance Sheet
Income Statement
1999
Revenues
$40.9
Net Loss
Before One-time Charges
67.5
Balance Sheet
1999
Cash & Investments
(*)
Accumulated Deficit
74.7
$49.2
(470.4)
(*) Including restricted cash
2000
2000
$48.1
59.3
72.4
$35.1
(542.7)
After One-time Charges
2001
2001
$76.3
35.5
43.0
$40.1
(585.7)
2002 (1H)
$44.1
16.8
18.8
2002 (1H)
$44.7
(604.5)
Convertible Debt
129.7
126.9
135.9
2.5
Previous slide
Next slide
Back to first slide
View graphic version